HIV: Disease Trajectory and Hospice Eligibility

Size: px
Start display at page:

Download "HIV: Disease Trajectory and Hospice Eligibility"

Transcription

1 HIV: Disease Trajectory and Hospice Eligibility Terri L. Maxwell, PhD, APRN VP, Strategic Initiatives Weatherbee Resources Inc Hospice Education Network Inc Course Handouts & Post Test To download presentation handouts, click on the attachment icon Presenter discloses no financial relationships with a commercial entity producing healthcare-related products and/or services. Conflict of interest disclosure and resolution statement is on file with HEN. This presentation is for educational and informational purposes only. It is not intended to provide legal, technical or other professional services or advice. Course Objectives At the end of this session, participants will be able to: 1. Describe clinical documentation criteria that supports clinical eligibility for HIV Disease based upon LCD Guidelines 2. Describe the importance of secondary and comorbid disease(s) conditions on the terminal trajectory of HIV Disease. 3. Describe secondary and comorbid disease(s) conditions associated with HIV. 1

2 HIV (Human Immunodeficiency Virus) HIV is a virus that attacks and destroys key components of the body s immune system, T cells or CD4 cells. Destruction of large numbers of CD4 cells leads to AIDs AIDS (Acquired Immune Deficiency Syndrome) is the final stage of HIV infection. Patients with AIDs are at risk for opportunistic infections. HIV Prevalence CDC estimates that more than one million people are living with HIV in the U.S. One in five living with HIV is unaware of their infection Gay and bisexual men are most severely affected By race, African Americans face the most severe HIV burden More than 17,000 people with AIDs died in % of hospice admissions are those with HIV Symptoms Associated with HIV/AIDs Fatigue Diarrhea Nausea/vomiting Fever, chills, night sweats Wasting syndrome Affective Disorders Dementia Cough/dyspnea Mouth sores Pressure ulcers Rash/pruritus 2

3 Secondary Conditions Associated with HIV/AIDs Kaposi s sarcoma Lymphoma Renal failure Opportunistic infections such as cryptosporidium or toxoplasmosis AIDs dementia Wasting syndrome LCD Guidelines for Hospice Eligibility and Recertification for HIV NGS LCD Number L25678 CGS LCD Number L32015 NHIC LCD Number L29881 Part III Disease-Specific Guideline Note: These guidelines are to be used in conjunction with the Non-disease specific baseline guidelines described in Part II of the LCD A. KPS / PPS < 50% B. Two or more ADL dependence C. Co-morbidities that contribute to life expectancy of 6 months or less 3

4 HIV Disease LCD Guidelines Per the LCD 1 and 2 must be present; 3 is used to add supporting documentation: 1. CD4+ Count <25 cells/mclor persistent viral load > 100,000 copies/ml, plus one of the following: CNS lymphoma Untreated, or not responsive to treatment, wasting (loss of 33% lean body mass) Mycobacterium aviumcomplex (MAC) bacteremia, untreated, unresponsive to treatment, or treatment refused Progressive multifocal leukoencephalopathy HIV Disease LCD Guidelines cont d Systemic lymphoma with advanced HIV disease and partial response to chemotherapy Visceral Kaposi s sarcoma unresponsive to therapy Renal failure in the absence of dialysis Cryptosporidum infection Toxoplasmosis, unresponsive to therapy HIV Disease LCD Guidelines cont d 2. Decreased performance status: KPS of < Documentation of the following support eligibility: Chronic persistent diarrhea for one year Persistent serum albumin <2.5 Concomitant, active substance abuse Age > 50 years No antiretroviral, chemotherapeutic & prophylactic drug therapy specifically related to HIV disease Advanced AIDS dementia complex Toxoplasmosis CHF, symptomatic at rest Advanced liver disease 4

5 Documentation example: Eligibility Thomas is a 57 yrold Caucasian male diagnosed with HIV/AIDS several years ago. Soc. Hx: Pt is homeless and an active substance abuser (heroin and cocaine). He was treated with antiretrovirals, but adherence was poor. He now has AIDs-related dementia and was recently hospitalized with a cryptosporidium infection and pneumonia. He has lost 60 lbsin the past 6 mos. (wt137 lbs, 6 1 ). He is dependent in 6/6 ADLs, KPS 40. He is incontinent of frequent loose stool. Appetite poor; requires hand feeding. He is not oriented to place or time. He was transferred to Sunshine Nursing Home and referred to hospice for supportive care. Family requests DNR and no hospitalization. Summary HIV/AIDs is now viewed as a chronic condition but patients still die secondary to AIDs-related complications LCD guidelines outline the clinical criteria for patients considered in the terminal phase of their illness. Documentation of concomitant secondary and co-morbid conditions support burden of illness and hospice eligibility. Course Handouts & Post Test Thank you for viewing this course on the Hospice Education Network The course evaluation and post test are available from your course catalog page 5

6 THANK YOU! Terri Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Inc. & Hospice Education Network 6

HIV: Disease Trajectory and Hospice Eligibility

HIV: Disease Trajectory and Hospice Eligibility HIV: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources/HEN Course Materials & Disclosure Course materials including handout(s) and conflict

More information

Course Handouts & Post Test

Course Handouts & Post Test STROKE/COMA: DISEASE TRAJECTORY AND HOSPICE ELIGIBILITY Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Post Test To download presentation

More information

Course Handouts & Disclosure

Course Handouts & Disclosure ALS: DISEASE TRAJECTORY AND HOSPICE ELIGIBILITY Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Inc Hospice Education Network Inc Course Handouts & Disclosure To download presentation

More information

Course Handouts & Disclosure

Course Handouts & Disclosure COPD: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Hospice Education Network Course Handouts & Disclosure To download presentation

More information

Course Handouts & Post Test

Course Handouts & Post Test End Stage Liver Disease (ESLD) End Stage Renal Disease (ESRD) Disease Trajectory and Hospice Eligibility Terri Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources Inc. & Hospice Education

More information

Renal Care and Liver Disease: Disease Trajectory and Hospice Eligibility

Renal Care and Liver Disease: Disease Trajectory and Hospice Eligibility Renal Care and Liver Disease: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources/HEN Course Materials & Disclosure Course materials including

More information

Hospice Eligibility August 2018

Hospice Eligibility August 2018 Hospice Eligibility August 2018 Objectives Identify who can make a hospice referral Review hospice eligibility and disease-specific prognostic indicators Review Open Access philosophy Who Can Make A Referral

More information

Alzheimer s Disease, Dementia, Related Disorders

Alzheimer s Disease, Dementia, Related Disorders Alzheimer s Disease, Dementia, Related Disorders Stage 7 on the FAST Scale signifies the threshold of activity limitation that would support a six-month prognosis. The FAST Scale does not address the impact

More information

Objectives 2/11/2016 HOSPICE 101

Objectives 2/11/2016 HOSPICE 101 HOSPICE 101 Overview Hospice History and Statistics What is Hospice? Who qualifies for services? Levels of Service The Admission Process Why Not to Wait Objectives Understand how to determine hospice eligibility

More information

Neurological Conditions: Disease Trajectory and Hospice Eligibility

Neurological Conditions: Disease Trajectory and Hospice Eligibility Neurological Conditions: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources/HEN Course Materials & Disclosure Course materials including

More information

HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning. Bill Wade R.N June 21,2005.

HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning. Bill Wade R.N June 21,2005. HIV/AIDS Primer for Nurse Practitioners Nursing is Attending to Meaning Bill Wade R.N June 21,2005. 1 Goals of this presentation Offer minimum content levels to enhance your learning needs around HIV/AIDS

More information

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission

10/17/2015. Chapter 55. Care of the Patient with HIV/AIDS. History of HIV. HIV Modes of Transmission Chapter 55 Care of the Patient with HIV/AIDS All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. History of HIV Remains somewhat obscure The earlier

More information

Table of Contents: Amyotrophic Lateral Sclerosis (ALS)

Table of Contents: Amyotrophic Lateral Sclerosis (ALS) Guidelines for Hospice Admission Amyotrophic Lateral Sclerosis (ALS) Cancer Cerebral Vascular Accident / Stroke or Coma Dementia / Alzheimer s Failure to Thrive Adults Heart Disease / CHF HIV Disease Huntington

More information

INTEGRATING HIV INTO PRIMARY CARE

INTEGRATING HIV INTO PRIMARY CARE INTEGRATING HIV INTO PRIMARY CARE ADELERO ADEBAJO, MD, MPH, AAHIVS, FACP NO DISCLOSURE 1.2 million people in the United States are living with HIV infection and 1 in 5 are unaware of their infection.

More information

Billing and Coding for HIV Services

Billing and Coding for HIV Services Billing and Coding for HIV Services Financial Disclosure This speaker does not have any financial relationships with commercial entities to disclose. This speaker will not discuss any off-label use or

More information

HOSPICE DIAGNOSIS DETERMINATION ASSESSMENT

HOSPICE DIAGNOSIS DETERMINATION ASSESSMENT Patient Name: MR #: Date: Objective documentation is required to support hospice admission. This worksheet is intended to gather information on both the severity and trajectory of the patient s condition

More information

Understanding THE SYMPTOMS YOU SEE

Understanding THE SYMPTOMS YOU SEE Understanding THE SYMPTOMS YOU SEE Z Human existence is rich with experiences that weave a completed quilt called life. As the quilt nears completion, there is no set calendar as to its final, beautiful

More information

11/2/2011 DOWNLOAD THE HANDOUTS OBJECTIVES. Determining Terminal Status: Dementia Due to Alzheimer s Disease and Related Disorders

11/2/2011 DOWNLOAD THE HANDOUTS OBJECTIVES. Determining Terminal Status: Dementia Due to Alzheimer s Disease and Related Disorders Determining Terminal Status: Dementia Due to Alzheimer s Disease and Related Disorders Joy Barry, RN, MEd, LNC Weatherbee Resources, Inc. Hospice Education Network, Inc. DOWNLOAD THE HANDOUTS Click on

More information

PHYSICIAN REFERENCE GUIDE FOR HOSPICE ELIGIBILITY. Office: (850) Fax: (850)

PHYSICIAN REFERENCE GUIDE FOR HOSPICE ELIGIBILITY.   Office: (850) Fax: (850) PHYSICIAN REFERENCE GUIDE FOR HOSPICE ELIGIBILITY www.regencyhospice.com Office: (850) 478-2695 Fax: (850) 478-9481 OUR MISSION The mission of Curo Health Services, and its hospice affiliates, is to honor

More information

Course Materials & Disclosure

Course Materials & Disclosure Pulmonary Disease: Disease Trajectory and Hospice Eligibility Terri L. Maxwell PhD, APRN VP, Strategic Initiatives Weatherbee Resources & Hospice Education Network Inc. Course Materials & Disclosure Course

More information

HIV/AIDS. Communication and Prevention. Davison Community Schools Grade Six June 2018

HIV/AIDS. Communication and Prevention. Davison Community Schools Grade Six June 2018 HIV/AIDS Communication and Prevention Davison Community Schools Grade Six June 2018 Discussing Sensitive Matters with Your Parents Parents: A child s first and most important teacher Parent s role is to

More information

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy

Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy Measure #161: HIV/AIDS: Adolescent and Adult Patients with HIV/AIDS Who Are Prescribed Potent Antiretroviral Therapy 2012 PHYSICIAN QUALITY REPTING OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

1. Townsend (2006) chapter 39 (pp ). 2. Townsend Pocket Guide (2004) chapter 18 (pp ).

1. Townsend (2006) chapter 39 (pp ). 2. Townsend Pocket Guide (2004) chapter 18 (pp ). BAPTIST HEALTH SCHOOL OF NURSING NSG 3037: PSYCHIATRIC-MENTAL HEALTH NURSING POPULATIONS AT RISK FOR ALTERATIONS IN HEALTH: PERSONS WITH HIV/AIDS and TERMINAL ILLNESS Sheryl F. Banak, MSN,RN Y1 LECTURE

More information

Helping Patients Navigate the Disability Process. Professor JoNel Newman, J.D.

Helping Patients Navigate the Disability Process. Professor JoNel Newman, J.D. Helping Patients Navigate the Disability Process Professor JoNel Newman, J.D. Goals What is the Social Security standard for HIV disability? How can you facilitate patient care and assist patients in this

More information

Hospice. Quick Reference Guide for Determining Eligibility for Hospice Care

Hospice. Quick Reference Guide for Determining Eligibility for Hospice Care Hospice Quick Reference Guide for Determining Eligibility for Hospice Care Hospice is a comprehensive service available to patients and their families who have a life expectancy of six months or less.

More information

Hospice & Palliative Care Referral Guidelines. (901)

Hospice & Palliative Care Referral Guidelines. (901) Hospice & Palliative Care Referral Guidelines Issued 2010 (901) 516-1600 www.methodisthealth.org Give us time to help your patients. Unfortunately, few patients and families receive the full benefit of

More information

Nursing Interventions

Nursing Interventions Chapter 16 H I Human Immunodeficiency V Virus A Acquired I Immuno D Deficiency S Syndrome Slide 1 Nursing Interventions Duty to treat Health care professionals may not pick and choose their patients Rehabilitation

More information

HOSPICE 101. Another choice for patients facing a terminal prognosis. De Anna Looper, RN, CHPN, CHPCA. Carrefour Associates L.L.C.

HOSPICE 101. Another choice for patients facing a terminal prognosis. De Anna Looper, RN, CHPN, CHPCA. Carrefour Associates L.L.C. HOSPICE 101 Another choice for patients facing a terminal prognosis. De Anna Looper, RN, CHPN, CHPCA Senior Vice President of Clinical Operations Carrefour Associates L.L.C. HOSPICE 101 Patients and their

More information

Immunodeficiencies HIV/AIDS

Immunodeficiencies HIV/AIDS Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement

More information

What Does HIV Do to You?

What Does HIV Do to You? What Does HIV Do to You? HIV and the immune system Your immune system is supposed to protect you from viruses and other infections. Why, then, doesn t it protect you from HIV? The answer is complicated,

More information

Hospice Eligibility Job Aid. Introduction/Importance

Hospice Eligibility Job Aid. Introduction/Importance Introduction/Importance Hospice care is a benefit under various insurance programs. Most hospice care in the United States is provided through Medicare. To be eligible to elect hospice care under Medicare

More information

Life is pleasant. Death is peaceful. It s the transition that s troublesome. Isaac Asimov ( )

Life is pleasant. Death is peaceful. It s the transition that s troublesome. Isaac Asimov ( ) Life is pleasant. Death is peaceful. It s the transition that s troublesome. Isaac Asimov (1920-1992) Objectives Palliative care versus hospice care. Admission guidelines to hospice services. Having the

More information

Acquired Immunodeficiency Syndrome (AIDS) By: Kendra Schapansky & Ariel Miller

Acquired Immunodeficiency Syndrome (AIDS) By: Kendra Schapansky & Ariel Miller Acquired Immunodeficiency Syndrome (AIDS) By: Kendra Schapansky & Ariel Miller HIV and AIDS HIV is a retrovirus that targets immune cells and transforms them into HIV-producing cells Progression to the

More information

Artificial Nutrition and Hydration at End of Life (EOL)

Artificial Nutrition and Hydration at End of Life (EOL) Artificial Nutrition and Hydration at End of Life (EOL) Sonali M Wilborn, MD, MBA National Medical Director Seasons Healthcare Management Seasons Hospice & Palliative Care 1 Objectives Define Artificial

More information

Clinical Manifestations of HIV

Clinical Manifestations of HIV HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from

More information

IEHP UM Subcommittee Approved Authorization Guidelines My Path (A Palliative Care Approach)

IEHP UM Subcommittee Approved Authorization Guidelines My Path (A Palliative Care Approach) UM_OTH 09 IEHP UM Subcommittee Approved Authorization Guidelines I. Policy: A. Inland Empire Health Plan (IEHP), in accordance with Senate Bill (SB) 1004, is dedicated to creating a community/home-based

More information

Eligibility Toolkit hosparus.org A non-profit hospice care provider

Eligibility Toolkit hosparus.org A non-profit hospice care provider Eligibility Toolkit 1-800-264-0521 hosparus.org A non-profit hospice care provider Our goal in partnering with you is to help residents/ patients live the rest of their lives as they wish, and to be comfortable

More information

HOSPICE IN A POCKET steinhospice.org. 3rd Edition. Indications for Hospice Referrals

HOSPICE IN A POCKET steinhospice.org. 3rd Edition. Indications for Hospice Referrals HOSPICE IN A POCKET 3rd Edition Indications for Hospice Referrals 1-800-625-5269 steinhospice.org Thank you for allowing Stein Hospice to be an extension of your services to the patients who turn to you

More information

Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013

Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 John F. White III, MD, MBA, FLMI VP and Medical Director American National Insurance Company 1 Mortality Rates Among People With HIV, Long on the Wane, Continue to Drop HIV Medicine Feb 2013 2 1 3 My Opinions

More information

http://www.savinglivesuk.com/ HIV Awareness Study Morning 24 th November 2017 Agenda HIV Basics & Stages of HIV HIV Testing, Health Advising & Sexual Health Saving Lives Antiretroviral Medication Antenatal/Postnatal

More information

QUARTERLY HIV/AIDS SURVEILLANCE REPORT

QUARTERLY HIV/AIDS SURVEILLANCE REPORT QUARTERLY HIV/AIDS SURVEILLANCE REPORT San Francisco Department of Public Health HIV/AIDS Cases Reported Through September 2010 Contents Page Surveillance Summary..... 1 Table 1: Adult/Adolescent HIV/AIDS

More information

Clinical Policy: Hospice Services Reference Number: CP.MP.54

Clinical Policy: Hospice Services Reference Number: CP.MP.54 Clinical Policy: Reference Number: CP.MP.54 Effective Date: 05/13 Last Review Date: 07/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

Hospice Admission Guidelines

Hospice Admission Guidelines Hospice Admission Guidelines www.hospiceheart.org Community Hospice Patients are eligible for hospice care when their physician determines the patient has a life expectancy of six (6) months or less. The

More information

CareFirst Hospice. Health care for the end of life. CareFirst

CareFirst Hospice. Health care for the end of life. CareFirst Hospice Health care for the end of life 1 What is Hospice? Hospice is a philosophy- When a person in end stages of an illness can no longer receive, or wants to receive, life sustaining treatment, he or

More information

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST

Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST Presented by: Melissa Egan, Regional Health Education Coordinator, CATIE Date: Tuesday October 8th, 2013, 1 2pm EST Agenda 1. HIV and the immune system 2. The progression of untreated HIV 3. Monitoring

More information

HIV/AIDS. Kuna High School Mr. Stanley

HIV/AIDS. Kuna High School Mr. Stanley HIV/AIDS Kuna High School Mr. Stanley Questions 1. Write an example of how your immune system helps prevent you from getting diseases. Terms to know Epidemic - a widespread occurrence of an infectious

More information

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body

HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body HIV 101: Overview of the Physiologic Impact of HIV and Its Diagnosis Part 2: Immunologic Impact of HIV and its Effects on the Body Melissa Badowski, PharmD, BCPS, AAHIVP Clinical Assistant Professor University

More information

The Struggle with Infectious Disease. Lecture 6

The Struggle with Infectious Disease. Lecture 6 The Struggle with Infectious Disease Lecture 6 HIV/AIDS It is generally believed that: Human Immunodeficiency Virus --------- causes ------------- Acquired Immunodeficiency Syndrome History of HIV HIV

More information

NEW PATIENT REGISTRATION

NEW PATIENT REGISTRATION NEW PATIENT REGISTRATION Hospital No. Date of Visit : / / Surname : First Name : Date of birth : / / Country of Birth : Sex : Male Female Transman Transwoman Other (please specify): Is this patient from

More information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Hospice Determining Terminal Status (L34538) Document Information

Contractor Information. LCD Information. Local Coverage Determination (LCD): Hospice Determining Terminal Status (L34538) Document Information Local Coverage Determination (LCD): Hospice Determining Terminal Status (L34538) Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD Website. Contractor Information

More information

Objectives. End-of-Life Exercise. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions.

Objectives. End-of-Life Exercise. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions. Palliative Care Can Help Patients and Decrease 30-Day Hospital Readmissions. Objectives Describe how palliative care meets the needs of the patient and family. Discuss how out-patient palliative care can

More information

Clinical Policy: Hospice Services Reference Number: PA.CP.MP.54

Clinical Policy: Hospice Services Reference Number: PA.CP.MP.54 Clinical Policy: Reference Number: PA.CP.MP.54 Effective Date: 01/18 Last Review Date: 10/17 Coding Implications Revision Log Description Medical necessity for hospice services. Policy It is the policy

More information

J6 Hospice Nursing Documentation

J6 Hospice Nursing Documentation J6 Nursing Documentation Supporting Terminal Prognosis 1536_0415 Today s Presenters Corrinne Ball, RN, CPC, CAC, CACO Provider Outreach and Education Consultant 2 Disclaimer National Government Services,

More information

HIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018

HIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018 HIV: What Every Clinician Needs to Know ARIZONA STATE ASSOCIATION OF PHYSICIAN ASSISTANTS SPRING CONFERENCE BETTIE COPLAN MARCH 2018 Overview Overview recent trends in HIV incidence in the U.S. HIV screening

More information

How to Estimate a Six-Month Prognosis. Hospice by the Bay Physicians

How to Estimate a Six-Month Prognosis. Hospice by the Bay Physicians Dear Colleague: Your local nonprofit, Hospice by the Bay, is here to help you, the referring physician: 1) determine hospice eligibility in terminally ill patients, 2) have the hospice conversation with

More information

Medical Case Management Training Series Module 1. Anissa Ray & Vadim Kogan

Medical Case Management Training Series Module 1. Anissa Ray & Vadim Kogan Medical Case Management Training Series Module 1 Anissa Ray & Vadim Kogan 6/9/2016 The Goal of This Training: Give you the HIV Knowledge you need to support your clients Help you Understand what these

More information

HIV/AIDS. The Essential Facts

HIV/AIDS. The Essential Facts HIV/AIDS The Essential Facts Educating the Church About HIV/AIDS Over the past decade, limited attention has been paid to the human immunodeficiency virus (HIV) epidemic in the United States. New England

More information

AWACC-2011 ART in the Inpatient Setting

AWACC-2011 ART in the Inpatient Setting AWACC-2011 ART in the Inpatient Setting Why no ART preparation for inpatients? 1.No link between inpatient and outpatient programmes HIV and AIDS services are delivered by well-funded but separate vertical

More information

Definitions. Appendix A

Definitions. Appendix A Definitions Appendix A 1. Blood means human blood, human blood components, and products made from human blood. 2. Bloodborne Pathogens means pathogenic microorganisms that are present in human blood and

More information

medical monitoring: clinical monitoring and laboratory tests

medical monitoring: clinical monitoring and laboratory tests medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify

More information

H - Human. A - Acquired I - Immunodeficiency I - Immune V - Virus D - Deficiency S - Syndrome

H - Human. A - Acquired I - Immunodeficiency I - Immune V - Virus D - Deficiency S - Syndrome Definition of Terms H - Human A - Acquired I - Immunodeficiency I - Immune V - Virus D - Deficiency S - Syndrome How is HIV Transmitted? Risk Behaviors Unprotected anal, oral, and vaginal intercourse Sharing

More information

Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years

Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years 06-ID-02 Committee: Infectious Disease Title: Revision of the Surveillance Case Definition for HIV Infection and AIDS Among children age > 18 months but < 13 years Statement of problem: Advances in HIV

More information

LCD for HOSPICE -- Determining Terminal Status (L13653)

LCD for HOSPICE -- Determining Terminal Status (L13653) LCD for HOSPICE -- Determining Terminal Status (L13653) Contractor Information Contractor Name Cahaba GBA, LLC - Midwest Contractor Number 00011 Contractor Type RHHI LCD ID Number L13653 LCD Information

More information

CLAUDINE HENNESSEY & THEUNIS HURTER

CLAUDINE HENNESSEY & THEUNIS HURTER HIV/AIDS/TB CLAUDINE HENNESSEY & THEUNIS HURTER KEY TERMS Do these sound familiar? What strange terms do you hear in the clinics? Any others to add?? HIV AIDS Viral Load & suppression CD4 count Regimen

More information

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003

Chapter 13 Viruses, Viroids, and Prions. Biology 1009 Microbiology Johnson-Summer 2003 Chapter 13 Viruses, Viroids, and Prions Biology 1009 Microbiology Johnson-Summer 2003 Viruses Virology-study of viruses Characteristics: acellular obligate intracellular parasites no ribosomes or means

More information

HIV and Long Term Disability

HIV and Long Term Disability HIV and Long Term Disability Minnesota AIDS Project The Minnesota AIDS Project envisions a world free of AIDS. Our mission is to lead Minnesota's fight to stop HIV through advocacy, education, and service.

More information

General HIV/AIDS Information

General HIV/AIDS Information General HIV/AIDS Information The History of HIV In the summer of 1981, physicians in San Francisco observed that young, previously healthy homosexual men were developing an unusual type of pneumonia which

More information

OI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco

OI prophylaxis When to start, when to stop. Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco OI prophylaxis When to start, when to stop Eva Raphael, MD MPH Family and community medicine, pgy-2 University of California, San Francisco Learning Objectives o Recognize when to start OI prophylaxis

More information

Evaluations. Featured Speakers. Thank You to Our Sponsors: 9/15/2015. Conflict of Interest & Disclosure Statements

Evaluations. Featured Speakers. Thank You to Our Sponsors: 9/15/2015. Conflict of Interest & Disclosure Statements Evaluations Nursing Contact Hours, CME and CHES credits are available. Please visit www.phlive.org to fill out your evaluation and complete the post-test. Conflict of Interest & Disclosure Statements The

More information

Running Head: HIV/AIDS 1. Medical Nutrition Therapy and HIV

Running Head: HIV/AIDS 1. Medical Nutrition Therapy and HIV Running Head: HIV/AIDS 1 Medical Nutrition Therapy and HIV HIV/AIDS 2 Medical Nutrition Therapy and HIV Introduction Mr. W is in the last stage of HIV AIDS. He visited the rehabilitation program last year.

More information

Painting a Picture of Eligibility Through Documentation

Painting a Picture of Eligibility Through Documentation 2017 ALL RIGHTS RESERVED R&C HEALTHCARE SOLUTIONS Painting a Picture of Eligibility Through Documentation CHARLENE ROSS, MBA, MSN, RN C ONSULTANT/EDUCATOR R &C HEALTHCARE SOLUTIONS & HOSPICE FUNDAMENTALS

More information

HIV and Public Health: the Basics

HIV and Public Health: the Basics HIV and Public Health: the Basics Joy Zeh, RN, MS, Family Nurse Practitioner VCU HIV/AIDS Center HIV and Public Health: the Basics Epidemiology Related Infections and Co-Morbidities Spectrum of HIV Infection

More information

Clinical Policy: Hospice Services Reference Number: CA.CP.MP.54

Clinical Policy: Hospice Services Reference Number: CA.CP.MP.54 Clinical Policy: Reference Number: CA.CP.MP.54 Effective Date: 05/13 Last Review Date: 01/18 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

The Italian AIDS Epidemic Supports The Chemical AIDS Theory. Daniele Mandrioli

The Italian AIDS Epidemic Supports The Chemical AIDS Theory. Daniele Mandrioli The Italian AIDS Epidemic Supports The Chemical AIDS Theory Daniele Mandrioli EPIDEMIOLOGY France Population: 65.073.482 AIDS Incidence: 16/million Germany Population: 82.438.000 AIDS Incidence: 4/million

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Rhee C, Jones TM, Hamad Y, et al; Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program. Prevalence, underlying causes, and preventability of sepsis-associated

More information

8/10/2017. HIV UPDATE 2017 David M Stein DO, FACOI

8/10/2017. HIV UPDATE 2017 David M Stein DO, FACOI HIV UPDATE 2017 David M Stein DO, FACOI 1 Current US HIV data 1.1 million HIV positive 1 out of 7 positive are unaware of their status Highest risk in Gay and Bisexual men, young African American men 2

More information

227 28, 2010 MIDTERM EXAMINATION KEY

227 28, 2010 MIDTERM EXAMINATION KEY Epidemiology 227 April 28, 2010 MIDTERM EXAMINATION KEY Select the best answer for the multiple choice questions. There are 64 questions and 9 pages on the examination. Each question will count one point.

More information

Introduction to HIV and Aging

Introduction to HIV and Aging Introduction to HIV and Aging Sheree Starrett MD Medical Director - Rivington House June 27, 2008 Rivington House Objectives Know the demographics of aging and HIV Identify the similarities between aging

More information

HIV/AIDS. Symptoms. Short view on symptoms and complaints

HIV/AIDS. Symptoms. Short view on symptoms and complaints HIV/AIDS Symptoms Short view on symptoms and complaints The symptoms of AIDS are primarily the result of conditions that do not normally develop in individuals with healthy immune systems. Most of these

More information

Revision of 11/15/2017 Form # 249 Page 1 of 7 Pilot Clinical Trials in CKD Follow-Up Pill Dispensing and Counting Form # COMBINE

Revision of 11/15/2017 Form # 249 Page 1 of 7 Pilot Clinical Trials in CKD Follow-Up Pill Dispensing and Counting Form # COMBINE Revision of 11/15/2017 Form # 249 Page 1 of 7 Pilot Clinical Trials in CKD Follow-Up Pill Dispensing and Counting Form # 249 - COMBINE This form is completed for all Protocol visits and for any extra follow-up

More information

NYS Right-to-Know Law. Protects your rights to information about hazardous materials that are used or stored at your place of work.

NYS Right-to-Know Law. Protects your rights to information about hazardous materials that are used or stored at your place of work. NYS Right-to-Know Law Protects your rights to information about hazardous materials that are used or stored at your place of work. RTK Enforcement NYS RTK law is enforced in public schools through the

More information

When to start: guidelines comparison

When to start: guidelines comparison The editorial staff When to start: guidelines comparison The optimal time to begin antiretroviral therapy remains a critical question for the HIV field, and consensus about the appropriate CD4+ cell count

More information

MYTHS OR FACTS OF STI s True or False

MYTHS OR FACTS OF STI s True or False Viral STI s MYTHS OR FACTS OF STI s True or False 1. There is no cure for herpes or AIDS. 2. Condoms protect against STI s. 3. If two people are free from STI s and have no other sexual partners, they

More information

Drafting a Coverage Authorization Request Letter

Drafting a Coverage Authorization Request Letter Drafting a Coverage Authorization Request Letter The following information is presented for informational purposes only and is not intended to provide reimbursement or legal advice. Laws, regulations,

More information

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease

Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Lahey Clinic Internal Medicine Residency Program: Curriculum for Infectious Disease Faculty representative: Eva Piessens, MD, MPH Resident representative: Karen Ganz, MD Revision date: February 1, 2006

More information

Welcome to Carolinas CARE Partnership. HIV A to Z: 6/30/2015. Objectives. The Basics and Beyond. Introductions Pre-Test Expectations

Welcome to Carolinas CARE Partnership. HIV A to Z: 6/30/2015. Objectives. The Basics and Beyond. Introductions Pre-Test Expectations Welcome to Carolinas CARE Partnership HIV A to Z: The Basics and Beyond Introductions Pre-Test Expectations Objectives Distinguish and define HIV and AIDS Brief history of the origin of HIV and AIDS Explain

More information

How is it transferred?

How is it transferred? STI s What is a STI? It is a contagious infection that is transferred from one person to another through sexual intercourse or other sexually- related behaviors. How is it transferred? The organisms live

More information

QUARTERLY AIDS SURVEILLANCE REPORT

QUARTERLY AIDS SURVEILLANCE REPORT QUARTERLY AIDS SURVEILLANCE REPORT San Francisco Department of Public Health AIDS Cases Reported Through June 2010 0 Contents Page Surveillance Summary..... 1 Table 1: Adult/Adolescent AIDS Cases by Transmission

More information

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead:

patients with blood borne viruses Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled Document Lead: CONTROLLED DOCUMENT Procedure for the management of patients with blood borne viruses CATEGORY: CLASSIFICATION: PURPOSE Controlled Document Number: Version Number: 4 Controlled Document Sponsor: Controlled

More information

San Francisco AIDS Cases Reported Through December 31, 1998

San Francisco AIDS Cases Reported Through December 31, 1998 San Francisco AIDS Cases Reported Through December 31, 1998 San Francisco Department of Public Health HIV Seroepidemiology and Surveillance Section AIDS Surveillance Unit Contents Page Commentary: Trends

More information

What is HIV? H -uman. I -mmunodefiency. V -irus Type of germ Lives and reproduces in body cells

What is HIV? H -uman. I -mmunodefiency. V -irus Type of germ Lives and reproduces in body cells BASIC FACTS ON HIV What is HIV? H -uman Found only in humans Transmitted among humans Preventable by humans I -mmunodefiency Body lacks ability to fight off infections V -irus Type of germ Lives and reproduces

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Dementia: the management of dementia, including the use of antipsychotic medication in older people 1.1 Short title Dementia 2 Background

More information

Immunodeficiency. (2 of 2)

Immunodeficiency. (2 of 2) Immunodeficiency (2 of 2) Acquired (secondary) immunodeficiencies More common Many causes such as therapy, cancer, sarcoidosis, malnutrition, infection & renal disease The most common of which is therapy-related

More information

Graying and HIV; The Mental Toll - Depression in Older LGBT Minorities

Graying and HIV; The Mental Toll - Depression in Older LGBT Minorities Graying and HIV; The Mental Toll - Depression in Older LGBT Minorities Ileana H. Nesbitt, Psy.D. Adler School of Professional Psychology HIV and Aging Committee AIDS Foundation of Chicago inesbitt@adler.edu

More information

Module 3: Symptom Management

Module 3: Symptom Management ELNEC- Public Hospitals End-of-Life Nursing Education Consortium Palliative Care For Public Hospitals Module 3: Symptom Management Course Handouts & Post Test To download presentation handouts, click on

More information

TRAJECTORY OF ILLNESS IN END OF LIFE CARE

TRAJECTORY OF ILLNESS IN END OF LIFE CARE TRAJECTORY OF ILLNESS IN END OF LIFE CARE By Dr Helen Fryer OBJECTIVES To be aware of the three commonest trajectories of decline in the UK To understand the challenges faced in delivering effective Palliative

More information

Determining Eligibility for Hospice Care

Determining Eligibility for Hospice Care Determining Eligibility for Hospice Care Main Number: 203 739-8300 Toll Free Number: 888 357-3334 www.regionalhospicect.org Many people may not understand all that Regional Hospice can offer or they are

More information

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012

Didactic Series. Primary HIV Infection. Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 Didactic Series Primary HIV Infection Greg Melcher, M.D. UC Davis AETC 8 Nov 2012 ACCREDITATION STATEMENT: University of California, San Diego School of Medicine is accredited by the Accreditation Council

More information

guide to living with cancer Brought to you by Alliance Health.

guide to living with cancer Brought to you by Alliance Health. guide to living with cancer Brought to you by Alliance Health. The content in this guide is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice

More information

CHART ELEVEN (11) KENYAN FIGURES (KENYA DEMOGRAPHIC HEALTH SURVEY REVISED 2004)

CHART ELEVEN (11) KENYAN FIGURES (KENYA DEMOGRAPHIC HEALTH SURVEY REVISED 2004) CHART ELEVEN (11) KENYAN FIGURES (KENYA DEMOGRAPHIC HEALTH SURVEY REVISED 2004) Adults living with HIV/AIDS - 1.1 million Children - 150,000 Number using ART - 24,000 Number needing ARVs - 200,000 National

More information